CIK: 0001600135
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SG7 | Sage Therapeutics INC | Stock-Other | 66.66% | -41.20% | -10.23% | |
| 2 | 2655787D | Blueprint Medicines CORP | Stock-Other | 20.38% | -5.65% | — | |
| 3 | ZFGNUSD | Zafgen INC | Stock-Other | 11.54% | -10.91% | -23.80% | |
| 4 | ✓ | Eleven Biotherapeutics INC | Stock-Other | 1.42% | -0.33% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SG7 | Sage Therapeutics INC | +14.3% | -10.23% | Trim |
| 2 | ✓ | Eleven Biotherapeutics INC | -3.2% | — | Unchanged |
| 3 | ZFGNUSD | Zafgen INC | -6.2% | -23.80% | Trim |
| 4 | ✓ | Foundation Medicine INC | — | EXIT | Sold out |
| 5 | 2655787D | Blueprint Medicines CORP | — | NEW | New buy |